CH535201A - Verfahren zur Spaltung von racemischen 2-(o-Chlorphenyl)-2-methylaminocyclohexanon in die optisch-aktiven Isomeren - Google Patents
Verfahren zur Spaltung von racemischen 2-(o-Chlorphenyl)-2-methylaminocyclohexanon in die optisch-aktiven IsomerenInfo
- Publication number
- CH535201A CH535201A CH1836870A CH1836870A CH535201A CH 535201 A CH535201 A CH 535201A CH 1836870 A CH1836870 A CH 1836870A CH 1836870 A CH1836870 A CH 1836870A CH 535201 A CH535201 A CH 535201A
- Authority
- CH
- Switzerland
- Prior art keywords
- methylaminocyclohexanone
- racemic
- chlorophenyl
- resolution
- optically active
- Prior art date
Links
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 title 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88679969A | 1969-12-19 | 1969-12-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH535201A true CH535201A (de) | 1973-03-31 |
Family
ID=25389797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1836870A CH535201A (de) | 1969-12-19 | 1970-12-11 | Verfahren zur Spaltung von racemischen 2-(o-Chlorphenyl)-2-methylaminocyclohexanon in die optisch-aktiven Isomeren |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPS4948542B1 (de) |
| BE (1) | BE760492A (de) |
| CH (1) | CH535201A (de) |
| DE (1) | DE2062620A1 (de) |
| ES (1) | ES386601A1 (de) |
| FR (1) | FR2081388B1 (de) |
| GB (1) | GB1330878A (de) |
| NL (1) | NL7018334A (de) |
| ZA (1) | ZA708468B (de) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5875614A (ja) * | 1981-10-28 | 1983-05-07 | Matsushita Electric Ind Co Ltd | 焼却炉の排ガス浄化装置 |
| DE4312016A1 (de) * | 1993-04-13 | 1994-10-20 | Goedecke Ag | Stabile Ketamin-Lösungen |
| DE19619665C2 (de) * | 1996-05-15 | 2001-03-08 | Goedecke Ag | Racemattrennung von Ketamin |
| BRPI0002693B8 (pt) * | 2000-06-19 | 2021-05-25 | Cristalia Produtos Quim Farmaceuticos Ltda | processo de obtenção dos enantiômeros da cetamina e seus sais farmaceuticamente aceitáveis |
| US7273889B2 (en) * | 2002-09-25 | 2007-09-25 | Innovative Drug Delivery Systems, Inc. | NMDA receptor antagonist formulation with reduced neurotoxicity |
| US20060063802A1 (en) | 2004-03-29 | 2006-03-23 | Matthieu Guitton | Methods for the treatment of tinnitus induced by cochlear excitotoxicity |
| US9072662B2 (en) | 2004-03-29 | 2015-07-07 | Auris Medical Ag | Methods for the treatment of tinnitus induced by cochlear excitotoxicity |
| US8268866B2 (en) | 2004-03-29 | 2012-09-18 | Matthieu Guitton | Methods for the treatment of tinnitus induced by cochlear excitotoxicity |
| CN101309667A (zh) | 2005-09-28 | 2008-11-19 | 奥里斯医学股份有限公司 | 治疗内耳疾病的药用合成物 |
| ES2862673T3 (es) | 2011-12-12 | 2021-10-07 | Zilentin AG | Tratamiento del tinnitus mediante la modulación del cotransportador de cloruro NKCC1 en el sistema auditivo |
| AU2014240102A1 (en) | 2013-03-15 | 2015-09-17 | Janssen Pharmaceutica Nv | Pharmaceutical composition of S-ketamine hydrochloride |
| US9872841B2 (en) | 2013-09-13 | 2018-01-23 | National University Corporation Chiba University | Application of R-ketamine and salt thereof as pharmaceuticals |
| CA2957926A1 (en) | 2014-08-13 | 2016-02-18 | Janssen Pharmaceutica Nv | Method for the treatment of depression |
| AU2015318123A1 (en) | 2014-09-15 | 2017-03-30 | Janssen Pharmaceutica Nv | Val66Met (SNP rs6265) genotype specific dosing regimens and methods for the treatment of depression |
| US20160332962A1 (en) * | 2015-05-13 | 2016-11-17 | Janssen Pharmaceutica Nv | (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine |
| US20200009081A1 (en) | 2017-09-13 | 2020-01-09 | Janssen Pharmaceutica N.V. | Delivery Of Esketamine For The Treatment Of Depression |
| IL319020A (en) | 2017-12-22 | 2025-04-01 | Janssen Pharmaceuticals Inc | Esketamine for the treatment of depression |
| BR112020016500A2 (pt) | 2018-02-15 | 2020-12-15 | National University Corporation Chiba University | Agente preventivo ou terapêutico e composição farmacêutica para doença inflamatória ou doença óssea |
| CN110218157B (zh) * | 2018-03-01 | 2022-08-23 | 江苏恒瑞医药股份有限公司 | 一种r-氯胺酮及其可药用盐的制备方法 |
| JP2021523228A (ja) | 2018-05-04 | 2021-09-02 | パーセプション ニューロサイエンス，インコーポレイティド | 物質乱用の治療方法 |
| EP3813807A1 (de) | 2018-06-27 | 2021-05-05 | Clexio Biosciences Ltd. | Verfahren zur behandlung einer schweren depressiven störung |
| KR20210074275A (ko) | 2018-10-05 | 2021-06-21 | 클렉시오 바이오사이언시스 리미티드 | 주요 우울 장애를 치료하기 위한 에스케타민의 복용 요법 |
| WO2020070706A1 (en) | 2018-10-05 | 2020-04-09 | Clexio Biosciences Ltd. | Dosage regime of esketamine for treating major depressive disorder |
| WO2020070547A1 (en) | 2018-10-05 | 2020-04-09 | Clexio Biosciences Ltd. | Dosage regime of esketamine for treating major depressive disorder |
| US12364672B2 (en) | 2018-10-11 | 2025-07-22 | Clexio Biosciences Ltd. | Esketamine for use in treating major depressive disorder |
| WO2020178653A1 (en) | 2019-03-05 | 2020-09-10 | Janssen Pharmaceuticals, Inc. | Esketamine for the treatment of depression |
| US12268658B2 (en) | 2019-12-30 | 2025-04-08 | Clexio Biosciences Ltd. | Dosage regime with esketamine for treating major depressive disorder |
| WO2021137148A1 (en) | 2019-12-30 | 2021-07-08 | Clexio Biosciences Ltd. | Dosage regime with esketamine for treating neuropsychiatric or neurological conditions |
| US12478592B2 (en) | 2019-12-30 | 2025-11-25 | Clexio Biosciences Ltd. | Dosage regime with esketamine for treating neuropsychiatric or neurological conditions |
| PH12022551856A1 (en) | 2020-01-22 | 2024-01-03 | Seelos Therapeutics Inc | Reducing side effects of nmda antagonists |
| CN112125816A (zh) * | 2020-03-17 | 2020-12-25 | 国药集团工业有限公司 | 一种氯胺酮、其衍生物或其盐的消旋化方法 |
| US20250082587A1 (en) | 2023-09-12 | 2025-03-13 | Clexio Biosciences Ltd. | Method Of Treating Major Depressive Disorder |
-
1970
- 1970-12-11 CH CH1836870A patent/CH535201A/de not_active IP Right Cessation
- 1970-12-15 ZA ZA708468A patent/ZA708468B/xx unknown
- 1970-12-16 NL NL7018334A patent/NL7018334A/xx unknown
- 1970-12-17 BE BE760492A patent/BE760492A/xx unknown
- 1970-12-18 ES ES386601A patent/ES386601A1/es not_active Expired
- 1970-12-18 DE DE19702062620 patent/DE2062620A1/de active Pending
- 1970-12-18 FR FR7045893A patent/FR2081388B1/fr not_active Expired
- 1970-12-18 GB GB6017370A patent/GB1330878A/en not_active Expired
- 1970-12-19 JP JP11363170A patent/JPS4948542B1/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| FR2081388A1 (de) | 1971-12-03 |
| DE2062620A1 (de) | 1971-07-15 |
| GB1330878A (en) | 1973-09-19 |
| FR2081388B1 (de) | 1974-06-21 |
| NL7018334A (de) | 1971-06-22 |
| ZA708468B (en) | 1972-02-23 |
| ES386601A1 (es) | 1974-01-16 |
| JPS4948542B1 (de) | 1974-12-21 |
| BE760492A (fr) | 1971-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH535201A (de) | Verfahren zur Spaltung von racemischen 2-(o-Chlorphenyl)-2-methylaminocyclohexanon in die optisch-aktiven Isomeren | |
| CH512427A (de) | Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Phenoxy-2-hydroxy-3-sec. -alkylaminopropanen | |
| CH544736A (de) | Verfahren zur Herstellung von Bromnitroalkoholen | |
| CH537358A (de) | Verfahren zur Herstellung von Bromnitroalkoholen | |
| CH504258A (de) | Verfahren zur Herstellung von Grobblechen | |
| AT311658B (de) | Verfahren zur kontinuierlichen herstellung von planebenen bauplatten | |
| CH526501A (de) | Verfahren zum Racemisieren von optisch aktiven trans-Cyclopropancarbonsäuren | |
| AT301517B (de) | Verfahren zur Herstellung von racemischer oder optisch aktiver cis-Chrysanthemumsäure | |
| CH456134A (de) | Verfahren zur Herstellung von Pressplatten | |
| AT329527B (de) | Verfahren zur herstellung von gesattigten aliphatischen alkoholen | |
| CH544055A (de) | Verfahren zur Herstellung von racemischen Gemischen oder optisch aktiven Isomeren von 5-Cyclohexyl-1-indancarbonsäuren | |
| AT284081B (de) | Verfahren zur Gewinnung der optisch aktiven Antipoden der trans-Chrysanthemumsäure | |
| CH521310A (de) | Verfahren zur Herstellung von neuen racemischen oder optisch aktiven substituierten 1-Phenoxy-2-hydroxy-3-alkylaminopropanen | |
| AT329721B (de) | Verfahren zur herstellung von wasch- und reinigungsmitteln | |
| AT301504B (de) | Verfahren zur Herstellung von Alkoholen | |
| AT305961B (de) | Verfahren zur Herstellung von Bromnitroalkoholen | |
| CH501634A (de) | Verfahren zur Aufspaltung von racemischem a-Aminocaprolactam oder racemischem N-Carbamylvalin in die optisch aktiven Enantiomeren | |
| AT325204B (de) | Verfahren zur umwandlung von penicillin-s-oxyden in die entsprechenden desacetoxycephalosporine | |
| CH526561A (de) | Verfahren zur Herstellung von 2-(3-Pyrrolidinyl)-isoindolinen | |
| CH515864A (de) | Verfahren zur Herstellung von optisch aktivem Methioninnitril | |
| AT316533B (de) | Verfahren zur Herstellung von optisch aktiven Bicyclen | |
| CH543467A (de) | Verfahren zur Herstellung von 2-(6-Methoxy-2-naphthyl)-1-propanol | |
| CH533067A (de) | Verfahren zur Spaltung von racemischen Gemischen von 3-Succinyloxy-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on-derivaten inoptische Antipoden | |
| AT288339B (de) | Verfahren zur Herstellung von Alkoholen | |
| AT296237B (de) | Verfahren zur Herstellung von Bromnitroalkoholen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |